BeiGene, Ltd. (ONC) Tops Q4 EPS by 77c, provides guidance

BeiGene, Ltd. (NASDAQ: ONC) reported Q4 EPS of ($0.11), $0.77 better than the analyst estimate of ($0.88). Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.05 billion.

GUIDANCE:

BeiGene, Ltd. sees FY2025 revenue of $4.9-5.3 billion, versus the consensus of $4.742 billion.

For earnings history and earnings-related data on BeiGene, Ltd. (ONC) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Micron Technology (MU) call put ratio 1.4 calls to 1 put on 1.2M contracts as share price up 4%
• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'